1845P Features of clinical trials leading to oncologic drugs approval in europe.
Saved in:
| Title: | 1845P Features of clinical trials leading to oncologic drugs approval in europe. |
|---|---|
| Authors: | Duranti, S.1 (AUTHOR), Lombardi, P.2 (AUTHOR), Falcone, R.2 (AUTHOR), Filetti, M.2 (AUTHOR), Pietragalla, A.1 (AUTHOR), Sterbini, F. Paroni2 (AUTHOR), Lorusso, D.1 (AUTHOR), Fabi, A.1 (AUTHOR), Nero, C.1 (AUTHOR), Ciccarone, F.1 (AUTHOR), Scambia, G.1 (AUTHOR), Daniele, G.2 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS1244-S1245. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152689081 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1845P Features of clinical trials leading to oncologic drugs approval in europe. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Duranti%2C+S%2E%22">Duranti, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lombardi%2C+P%2E%22">Lombardi, P.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falcone%2C+R%2E%22">Falcone, R.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Filetti%2C+M%2E%22">Filetti, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pietragalla%2C+A%2E%22">Pietragalla, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sterbini%2C+F%2E+Paroni%22">Sterbini, F. Paroni</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fabi%2C+A%2E%22">Fabi, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nero%2C+C%2E%22">Nero, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ciccarone%2C+F%2E%22">Ciccarone, F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scambia%2C+G%2E%22">Scambia, G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Daniele%2C+G%2E%22">Daniele, G.</searchLink><relatesTo>2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 5, Vol. 32, pS1244-S1245. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152689081 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2021.08.733 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S1244 Titles: – TitleFull: 1845P Features of clinical trials leading to oncologic drugs approval in europe. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Duranti, S. – PersonEntity: Name: NameFull: Lombardi, P. – PersonEntity: Name: NameFull: Falcone, R. – PersonEntity: Name: NameFull: Filetti, M. – PersonEntity: Name: NameFull: Pietragalla, A. – PersonEntity: Name: NameFull: Sterbini, F. Paroni – PersonEntity: Name: NameFull: Lorusso, D. – PersonEntity: Name: NameFull: Fabi, A. – PersonEntity: Name: NameFull: Nero, C. – PersonEntity: Name: NameFull: Ciccarone, F. – PersonEntity: Name: NameFull: Scambia, G. – PersonEntity: Name: NameFull: Daniele, G. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2021 Supplement 5 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 32 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |